Lifeline BioTechnologies, Inc. Continues FDA Filing Preparation Process for the First Warning System(TM)

September 1, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) announced today that it has retained a new FDA consulting company to assist in the preparation and filing of its First Warning System™ 510(k) application.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory

Food and Drug Administration (FDA)